New Launch5 Sept 2025, 05:07 pm
Trident Lifeline's Transformative Year: Expanded Production, Diversified Portfolio, and Global Growth in FY25
AI Summary
Trident Lifeline Limited, a fast-growing pharmaceutical company, had a transformative FY25. The company commissioned a new manufacturing facility, strengthened its portfolio through acquisitions, and expanded its global footprint. This strategic combination of organic expansion and targeted acquisitions has not only accelerated growth but also reinforced resilience. The financial results reflect the success of this approach, with revenue and EBITDA showing significant increases.
Key Highlights
- Commissioning of a new manufacturing facility of TNS Pharma Private Limited
- Launch of TLL Elements in the skin and hair care space
- Acquisition of majority stakes in TLL Parenterals for injectables
- Acquisition of Trident Mediquip in the medical devices domain
- Expansion of global footprint across 43 countries